Prognos
7 known investors
Prognos Health provides integrated and harmonized clinical and genomic laboratory data, combined with claims data, on hundreds of millions of de-identified patients in the US. It serves the pharmaceutical and life sciences industry with real-world data for commercial analytics, HCP targeting, and therapy development across therapeutic areas including rare disease and oncology.
Founders & leadership
SB
Sundeep BhaninFounder
Investors · 7
In the news
Frequently asked questions
- What does Prognos do?
- Prognos Health provides integrated and harmonized clinical and genomic laboratory data, combined with claims data, on hundreds of millions of de-identified patients in the US. It serves the pharmaceutical and life sciences industry with real-world data for commercial analytics, HCP targeting, and therapy development across therapeutic areas including rare disease and oncology.
- Who founded Prognos?
- Prognos was founded by Sundeep Bhan.
- Who are Prognos's investors?
- Prognos's investors include Hikma Ventures, Maywic Select Investments, Montage Capital, Partners for Growth, Partners for Growth (PFG), Red & Blue Ventures, Merck Global Health Innovation Fund.